A Pilot Study: "Analysis of Serum miRNA from Women Referred for Breast Biopsy with Abnormal Breast Imaging Classified as BI-RADS 4 or 5"
By drawing a tube of blood, data is obtained that will hopefully improve the breast cancer screening process in the future. Researchers are looking at serum miRNA signatures to determine if a subsequent breast biopsy has a higher likelihood of being positive or negative. This study is recruiting patients have breast imaging studies suspicious for cancer discovered during screening.
Stephanie Porenta, RN BSN CCRC: 425.467.3986, Stephanie.Porenta@overlakehospital.org
Pooja Rajeevan, CRC: 425.635.6081, Pooja.Rajeevan@overlakehospital.org
Clinical Trial Categories